Medeon Biodesign Capital Reinvestment Ratio
Medeon Biodesign capital reinvestment ratio. Medeon Biodesign (6499) has a Capital Reinvestment Ratio of 0.68x as of March 2022, meaning it reinvests 1% of its operating cash flow (NT$60.74 Million) in capital expenditures (NT$41.12 Million). Check cash flow reinvestment rate of Medeon Biodesign to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Medeon Biodesign (2018–2018)
Capital reinvestment ratio of Medeon Biodesign from 2018 to 2018. This chart tracks Medeon Biodesign's Capital Reinvestment Ratio across 1 annual periods. Also explore Medeon Biodesign equity growth rate to track the company's year-over-year net asset growth rate.
Medeon Biodesign Capital Reinvestment Ratio by Year (2018–2018)
Medeon Biodesign capital reinvestment ratio by year from 2018 to 2018. For the full cash flow conversion analysis, see cash efficiency ratio of Medeon Biodesign.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.16x | NT$322.05 Million | NT$51.14 Million | — |